Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Mäkelä, Katja
DOB:	28-NOV-1954 (Age: 71)
Gender:	female
Address:	Uudenkaupunginkuja 53 43100 Saarijärvi (Finland)
ID:	6615-747498-3 (ECI)

Report
Date:	21-MAR-2025

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Vesannon terveyskeskus Terveystie (Finland)

Specimen
Collected:	21-MAR-2025

Chemistry

Test	21-MAR-2025	Reference Range	Unit
Glucose [Mass/volume] in Blood	83.2	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	9.9	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	3.3 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.6 - 10.3	mg/dL
Sodium [Moles/volume] in Blood	142.6	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.9	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	107.7	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	24.5	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	6.9	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	3.9	3.5 - 5.0	g/dL
Globulin [Mass/volume] in Serum by calculation	3.2 L	25 - 35	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.5	0.1 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	129.7 H	32 - 91	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	49.1	7 - 56	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	25.0	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	166.4	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	199.7 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	100.2 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	32.9 L	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, suggesting impaired renal function, and increased alkaline phosphatase, which may indicate hepatobiliary or bone involvement. Lipid profile reveals high triglycerides, borderline high LDL, and low HDL, increasing cardiovascular risk. Low globulin may reflect protein imbalance or laboratory error (unit discrepancy noted). Other parameters are within normal limits. Recommend further evaluation of renal and liver function, and cardiovascular risk management.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated creatinine, suggesting impaired renal function, and increased alkaline phosphatase, which may indicate hepatobiliary or bone involvement. Lipid profile reveals high triglycerides, borderline high LDL, and low HDL, increasing cardiovascular risk. Low globulin may reflect protein imbalance or laboratory error (unit discrepancy noted). Other parameters are within normal limits. Recommend further evaluation of renal and liver function, and cardiovascular risk management.